{"id":"https://openalex.org/W4387693232","doi":"https://doi.org/10.1136/jitc-2023-007637","title":"Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma","display_name":"Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387693232","doi":"https://doi.org/10.1136/jitc-2023-007637","pmid":"https://pubmed.ncbi.nlm.nih.gov/37848259","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10582968"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-007637","doi":"https://doi.org/10.1136/jitc-2023-007637","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007637","pdf_url":"https://jitc.bmj.com/content/jitc/11/10/e007637.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4387693232"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/10/e007637.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050782218","display_name":"Philip R. Clingan","orcid":"https://orcid.org/0000-0002-4766-9954","observed_orcids":["https://orcid.org/0000-0002-4766-9954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip Clingan","raw_affiliation_strings":["Southern Medical Day Care Centre, Wollongong, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Southern Medical Day Care Centre, Wollongong, New South Wales, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028812401","display_name":"Rahul Ladwa","orcid":"https://orcid.org/0000-0002-4196-0177","observed_orcids":["https://orcid.org/0000-0002-4196-0177"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I2801814493","display_name":"Princess Alexandra Hospital","ror":"https://ror.org/04mqb0968","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2801244131","https://openalex.org/I2801814493","https://openalex.org/I4210089726"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Rahul Ladwa","raw_affiliation_strings":["Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I165143802","https://openalex.org/I2801814493"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059404809","display_name":"Daniel Brungs","orcid":"https://orcid.org/0000-0002-8154-6966","observed_orcids":["https://orcid.org/0000-0002-8154-6966"]},"institutions":[{"id":"https://openalex.org/I204824540","display_name":"University of Wollongong","ror":"https://ror.org/00jtmb277","country_code":"AU","type":"education","lineage":["https://openalex.org/I204824540"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Daniel Brungs","raw_affiliation_strings":["Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia","Southern Medical Day Care Centre, Wollongong, New South Wales, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia","institution_ids":["https://openalex.org/I204824540"]},{"raw_affiliation_string":"Southern Medical Day Care Centre, Wollongong, New South Wales, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104183800","display_name":"Dean Laurence Harris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802773633","display_name":"Christchurch Hospital","ror":"https://ror.org/003nvpm64","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I2802773633","https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Dean Laurence Harris","raw_affiliation_strings":["Christchurch Hospital, Christchurch, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christchurch Hospital, Christchurch, New Zealand","institution_ids":["https://openalex.org/I2802773633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017600333","display_name":"Margaret Louise McGrath","orcid":"https://orcid.org/0000-0002-6384-5540","observed_orcids":["https://orcid.org/0000-0002-6384-5540"]},"institutions":[{"id":"https://openalex.org/I2800214752","display_name":"Greenslopes Private Hospital","ror":"https://ror.org/05csdwp88","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800214752"]},{"id":"https://openalex.org/I4210121638","display_name":"Gallipoli Medical Research Foundation","ror":"https://ror.org/02p32hv70","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210121638"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Margaret McGrath","raw_affiliation_strings":["Medical Oncology, Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia","institution_ids":["https://openalex.org/I2800214752","https://openalex.org/I4210121638"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Susan Arnold","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Arnold","raw_affiliation_strings":["Exellentis Clinical Trial Consultants, George, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exellentis Clinical Trial Consultants, George, South Africa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053835464","display_name":"Jermaine Ian George Coward","orcid":"https://orcid.org/0000-0002-2309-9379","observed_orcids":["https://orcid.org/0000-0002-2309-9379"]},"institutions":[{"id":"https://openalex.org/I4210167184","display_name":"Icon (Australia)","ror":"https://ror.org/05nh0hr31","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210167184"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jermaine Coward","raw_affiliation_strings":["ICON Cancer Centre, South Brisbane, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICON Cancer Centre, South Brisbane, Queensland, Australia","institution_ids":["https://openalex.org/I4210167184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064076128","display_name":"Samuel Fourie","orcid":"https://orcid.org/0000-0003-3759-3201","observed_orcids":["https://orcid.org/0000-0003-3759-3201"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samuel Fourie","raw_affiliation_strings":["Wilgers Oncology Centre, Pretoria, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wilgers Oncology Centre, Pretoria, South Africa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108870939","display_name":"Andriy Kurochkin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andriy Kurochkin","raw_affiliation_strings":["Municipal Nonprofit Enterprise of Sumy Regional Council Sumy Regional Clinical Oncology Dispensary, Sumy, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Municipal Nonprofit Enterprise of Sumy Regional Council Sumy Regional Clinical Oncology Dispensary, Sumy, Ukraine","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013235830","display_name":"Daniel R Malan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel R Malan","raw_affiliation_strings":["Phoenix Pharma, Port Elizabeth, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phoenix Pharma, Port Elizabeth, South Africa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025798657","display_name":"Andrew Michael Mant","orcid":"https://orcid.org/0000-0002-1821-6374","observed_orcids":["https://orcid.org/0000-0002-1821-6374"]},"institutions":[{"id":"https://openalex.org/I4210098920","display_name":"Eastern Health","ror":"https://ror.org/00vyyx863","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210098920"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew Mant","raw_affiliation_strings":["Medical Oncology Unit, Eastern Health, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Eastern Health, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I4210098920"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100301960","display_name":"Vinay Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192619145","display_name":"University of the Witwatersrand","ror":"https://ror.org/03rp50x72","country_code":"ZA","type":"education","lineage":["https://openalex.org/I192619145"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Vinay Sharma","raw_affiliation_strings":["Wits Clinical Research Chris Hani Baragwanath Clinical Trial Site, Johannesburg, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wits Clinical Research Chris Hani Baragwanath Clinical Trial Site, Johannesburg, South Africa","institution_ids":["https://openalex.org/I192619145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080600427","display_name":"Hong Shue","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Shue","raw_affiliation_strings":["Sunshine Coast Haematology and Oncology Clinic, Buderim, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sunshine Coast Haematology and Oncology Clinic, Buderim, Queensland, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025420070","display_name":"Andrea Tazbirkova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Tazbirkova","raw_affiliation_strings":["Medical Oncology, Pindara Private Hospital, Gold Coast, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Pindara Private Hospital, Gold Coast, Queensland, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071710676","display_name":"Miguel\u2010\u00c1ngel Berciano\u2010Guerrero","orcid":"https://orcid.org/0000-0002-5437-5196","observed_orcids":["https://orcid.org/0000-0002-5437-5196"]},"institutions":[{"id":"https://openalex.org/I4210164724","display_name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga","ror":"https://ror.org/05n3asa33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210164724"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel-Angel Berciano-Guerrero","raw_affiliation_strings":["Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga, Spain"],"raw_orcid":"https://orcid.org/0000-0002-5437-5196","affiliations":[{"raw_affiliation_string":"Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, M\u00e1laga, Spain","institution_ids":["https://openalex.org/I4210164724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087683383","display_name":"Chaiyut Charoentum","orcid":"https://orcid.org/0000-0001-8659-8629","observed_orcids":["https://orcid.org/0000-0001-8659-8629"]},"institutions":[{"id":"https://openalex.org/I4210111088","display_name":"Maharaj Nakorn Chiang Mai Hospital","ror":"https://ror.org/01ze6tn69","country_code":"TH","type":"healthcare","lineage":["https://openalex.org/I4210111088"]},{"id":"https://openalex.org/I48076826","display_name":"Chiang Mai University","ror":"https://ror.org/05m2fqn25","country_code":"TH","type":"education","lineage":["https://openalex.org/I48076826"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Chaiyut Charoentum","raw_affiliation_strings":["Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand","institution_ids":["https://openalex.org/I4210111088","https://openalex.org/I48076826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073133195","display_name":"St\u00e9phane Dalle","orcid":"https://orcid.org/0000-0002-3423-4548","observed_orcids":["https://orcid.org/0000-0002-3423-4548"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210113288","display_name":"H\u00f4pital Lyon Sud","ror":"https://ror.org/023xgd207","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phane Dalle","raw_affiliation_strings":["Hospices Civils de Lyon - Hopital Lyon Sud, Pierre-B\u00e9nite, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospices Civils de Lyon - Hopital Lyon Sud, Pierre-B\u00e9nite, France","institution_ids":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053390754","display_name":"Arunee Dechaphunkul","orcid":"https://orcid.org/0000-0002-0593-4385","observed_orcids":["https://orcid.org/0000-0002-0593-4385"]},"institutions":[{"id":"https://openalex.org/I131868736","display_name":"Prince of Songkla University","ror":"https://ror.org/0575ycz84","country_code":"TH","type":"education","lineage":["https://openalex.org/I131868736"]},{"id":"https://openalex.org/I4210110554","display_name":"Songklanagarind Hospital","ror":"https://ror.org/01svaca56","country_code":"TH","type":"healthcare","lineage":["https://openalex.org/I4210110554"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Arunee Dechaphunkul","raw_affiliation_strings":["Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand","institution_ids":["https://openalex.org/I131868736","https://openalex.org/I4210110554"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044392466","display_name":"Oleksandr Dudnichenko","orcid":"https://orcid.org/0000-0001-8626-8435","observed_orcids":["https://orcid.org/0000-0001-8626-8435"]},"institutions":[{"id":"https://openalex.org/I2800747640","display_name":"Kharkiv Medical Academy of Postgraduate Education","ror":"https://ror.org/00zqqv187","country_code":"UA","type":"education","lineage":["https://openalex.org/I2800747640"]}],"countries":["UA"],"is_corresponding":false,"raw_author_name":"Oleksandr Dudnichenko","raw_affiliation_strings":["Kharkiv Medical Academy of Postgraduate Education, Chair of Oncology and Children's Oncology, Clinical base State institution \"VT Zaycev Institute of General and Urgent Surgery of National Academy Medical Sciences of Ukraine\", Kharkiv, Ukraine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kharkiv Medical Academy of Postgraduate Education, Chair of Oncology and Children's Oncology, Clinical base State institution \"VT Zaycev Institute of General and Urgent Surgery of National Academy Medical Sciences of Ukraine\", Kharkiv, Ukraine","institution_ids":["https://openalex.org/I2800747640"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075093602","display_name":"P. Koralewski","orcid":"https://orcid.org/0009-0004-5152-563X","observed_orcids":["https://orcid.org/0009-0004-5152-563X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piotr Koralewski","raw_affiliation_strings":["Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o., Oddzia\u0142 Onkologii Klinicznej z Pododdzia\u0142em Dziennym, Krak\u00f3w, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o., Oddzia\u0142 Onkologii Klinicznej z Pododdzia\u0142em Dziennym, Krak\u00f3w, Poland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041689810","display_name":"Iwona A. Lugowska","orcid":"https://orcid.org/0000-0001-9511-178X","observed_orcids":["https://orcid.org/0000-0001-9511-178X"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Iwona Lugowska","raw_affiliation_strings":["Narodowy Instytut Onkologii im. Marii Sk\u0142odowskiej-Curie Pa\u0144stwowy Instytut Badawczy, Oddzia\u0142 Bada\u0144 Wczesnych Faz, Warsaw, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Narodowy Instytut Onkologii im. Marii Sk\u0142odowskiej-Curie Pa\u0144stwowy Instytut Badawczy, Oddzia\u0142 Bada\u0144 Wczesnych Faz, Warsaw, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038569833","display_name":"Henri Montaudi\u00e9","orcid":"https://orcid.org/0000-0002-0528-4829","observed_orcids":["https://orcid.org/0000-0002-0528-4829"]},"institutions":[{"id":"https://openalex.org/I3018988418","display_name":"Centre Hospitalier Universitaire de Nice","ror":"https://ror.org/05qsjq305","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418"]},{"id":"https://openalex.org/I4210118460","display_name":"H\u00f4pital l'Archet","ror":"https://ror.org/02fsxgh46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418","https://openalex.org/I4210118460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Henri Montaudi\u00e9","raw_affiliation_strings":["Centre Hospitalier Universitaire de Nice - H\u00f4pital l'Archet, Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire de Nice - H\u00f4pital l'Archet, Nice, France","institution_ids":["https://openalex.org/I3018988418","https://openalex.org/I4210118460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058294413","display_name":"Eva Mu\u00f1oz\u2010Couselo","orcid":"https://orcid.org/0000-0001-7556-7608","observed_orcids":["https://orcid.org/0000-0001-7556-7608"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva Mu\u00f1oz-Couselo","raw_affiliation_strings":["Hospital Universitario Vall d'Hebron, Passeig de la Vall d'Hebron, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Vall d'Hebron, Passeig de la Vall d'Hebron, Vall d\u2019Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061940066","display_name":"Virote Sriuranpong","orcid":"https://orcid.org/0000-0001-8787-5026","observed_orcids":["https://orcid.org/0000-0001-8787-5026"]},"institutions":[{"id":"https://openalex.org/I2802209374","display_name":"King Chulalongkorn Memorial Hospital","ror":"https://ror.org/05jd2pj53","country_code":"TH","type":"healthcare","lineage":["https://openalex.org/I2802209374"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Virote Sriuranpong","raw_affiliation_strings":["King Chulalongkorn Memorial Hospital, Bangkok, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King Chulalongkorn Memorial Hospital, Bangkok, Thailand","institution_ids":["https://openalex.org/I2802209374"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003329133","display_name":"James Oliviero","orcid":"https://orcid.org/0009-0009-9857-1189","observed_orcids":["https://orcid.org/0009-0009-9857-1189"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"James Oliviero","raw_affiliation_strings":["Checkpoint Therapeutics Inc, Waltham, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0009-0009-9857-1189","affiliations":[{"raw_affiliation_string":"Checkpoint Therapeutics Inc, Waltham, Massachusetts, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078038970","display_name":"Jayesh Desai","orcid":"https://orcid.org/0000-0003-4246-9344","observed_orcids":["https://orcid.org/0000-0003-4246-9344"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jayesh Desai","raw_affiliation_strings":["Department of Medical Oncology, Peter MacCallum Cancer Centre; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia","Department of Medical Oncology, Peter MacCallum Cancer Centre","Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Peter MacCallum Cancer Centre; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]},{"raw_affiliation_string":"Department of Medical Oncology, Peter MacCallum Cancer Centre","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I165779595"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":25,"corresponding_author_ids":["https://openalex.org/A5003329133"],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":7.5802,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.98284807,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"11","issue":"10","first_page":"e007637","last_page":"e007637"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.38089999556541443,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.8149999976158142},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.7110000252723694},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6539999842643738},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.9620000123977661},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.972000002861023},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9729999899864197},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8310527801513672},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5443806052207947},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5397120714187622},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5313723087310791},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5177661180496216},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4692542254924774},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.46449971199035645},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43872296810150146},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3313310146331787},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32465410232543945},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28442829847335815}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1136/jitc-2023-007637","doi":"https://doi.org/10.1136/jitc-2023-007637","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007637","pdf_url":"https://jitc.bmj.com/content/jitc/11/10/e007637.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10582968","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10582968","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10582968/pdf/jitc-2023-007637.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:37848259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37848259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Multicenter Study"},{"id":"pmh:oai:HAL:hal-04941902v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-04941902","pdf_url":"https://hal.science/hal-04941902v1/file/jitc-2023-007637.pdf","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for Immunotherapy of Cancer, 2023, 11, ⟨10.1136/jitc-2023-007637⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:ro.uow.edu.au:test2021-15314","doi":null,"is_oa":false,"landing_page_url":"https://ro.uow.edu.au/test2021/9767","pdf_url":null,"source":{"id":"https://openalex.org/S4306400510","display_name":"Research Online (University of Wollongong)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I204824540","host_organization_name":"University of Wollongong","host_organization_lineage":["https://openalex.org/I204824540"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scopus Harvesting Series","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:ba79bd85b8124e27b03c0ee657e71ed1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ba79bd85b8124e27b03c0ee657e71ed1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-007637","doi":"https://doi.org/10.1136/jitc-2023-007637","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-007637","pdf_url":"https://jitc.bmj.com/content/jitc/11/10/e007637.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320311647","display_name":"Merck KGaA","ror":"https://ror.org/04b2dty93"},{"id":"https://openalex.org/F4320314128","display_name":"Les Laboratories Pierre Fabre","ror":"https://ror.org/04hdhz511"},{"id":"https://openalex.org/F4320317235","display_name":"BeiGene","ror":"https://ror.org/012v2c923"},{"id":"https://openalex.org/F4320319264","display_name":"MacroGenics","ror":"https://ror.org/01hcd4187"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320323491","display_name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie et de Pathologie Sexuellement Transmissible","ror":"https://ror.org/03gck1m55"},{"id":"https://openalex.org/F4320323775","display_name":"Cancerop\u00f4le PACA","ror":"https://ror.org/01mwvah42"},{"id":"https://openalex.org/F4320331856","display_name":"Australia and New Zealand Sarcoma Association","ror":"https://ror.org/02pad4n29"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387693232.pdf","grobid_xml":"https://content.openalex.org/works/W4387693232.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1529230314","https://openalex.org/W1600772273","https://openalex.org/W1987768576","https://openalex.org/W2032541700","https://openalex.org/W2155752258","https://openalex.org/W2740703372","https://openalex.org/W2745126191","https://openalex.org/W2756648224","https://openalex.org/W2790441065","https://openalex.org/W2792512660","https://openalex.org/W2793180707","https://openalex.org/W2805968856","https://openalex.org/W2894234470","https://openalex.org/W2899968320","https://openalex.org/W2913117321","https://openalex.org/W2940759533","https://openalex.org/W2973309783","https://openalex.org/W2982441853","https://openalex.org/W2985232046","https://openalex.org/W3004267116","https://openalex.org/W3008798432","https://openalex.org/W3020745962","https://openalex.org/W3035840030","https://openalex.org/W3043252982","https://openalex.org/W3046607405","https://openalex.org/W3094763051","https://openalex.org/W3095158308","https://openalex.org/W3134655285","https://openalex.org/W3166161392","https://openalex.org/W3196659388","https://openalex.org/W4200160482","https://openalex.org/W4205315499","https://openalex.org/W4206124656","https://openalex.org/W4295271013","https://openalex.org/W6795459662"],"related_works":["https://openalex.org/W4286294604","https://openalex.org/W4414620249","https://openalex.org/W3110489224","https://openalex.org/W4402558716","https://openalex.org/W7117285044","https://openalex.org/W3102540340","https://openalex.org/W3088128217","https://openalex.org/W7162514309","https://openalex.org/W4409327258","https://openalex.org/W7160135131"],"abstract_inverted_index":{"BACKGROUND:":[0],"Programmed":[1],"cell":[2,17,50],"death":[3],"receptor-1":[4],"(PD-1)-blocking":[5],"antibodies":[6],"are":[7],"approved":[8],"to":[9,173,183,196],"treat":[10],"metastatic":[11,102,121],"or":[12,25,33],"locally":[13],"advanced":[14],"cutaneous":[15],"squamous":[16],"carcinoma":[18],"(CSCC)":[19],"cases":[20],"ineligible":[21],"for":[22,42],"curative":[23],"surgery":[24],"radiation.":[26],"Notwithstanding,":[27],"some":[28],"patients":[29,100],"experience":[30],"inadequate":[31],"responses":[32],"severe":[34],"immune-related":[35,222],"adverse":[36],"events":[37],"(AEs),":[38],"indicating":[39],"the":[40,96],"need":[41],"improved":[43],"therapies.":[44],"Cosibelimab":[45,237],"is":[46,71],"a":[47,78,248],"high-affinity":[48],"programmed":[49],"death-ligand":[51],"1":[52,111],"(PD-L1)-blocking":[53],"antibody":[54],"that":[55],"activates":[56],"innate":[57],"and":[58,67,88,157,215,242,244],"adaptive":[59],"immunity":[60],"by":[61,138],"blocking":[62],"PD-L1":[63],"interaction":[64],"with":[65,77,101,120,175,199,247],"PD-1":[66],"B7-1":[68],"receptors.":[69],"It":[70],"an":[72,105],"unmodified":[73],"immunoglobulin":[74],"G1":[75],"subtype":[76],"functional":[79],"Fc":[80],"domain":[81],"capable":[82],"of":[83,95,99,113,154,166,178,186,204],"inducing":[84],"antibody-dependent":[85],"cellular":[86],"cytotoxicity":[87],"complement-dependent":[89],"cytotoxicity.":[90],"Here,":[91],"we":[92],"present":[93],"results":[94],"pivotal":[97],"study":[98],"CSCC":[103,122],"from":[104],"open-label,":[106],"multicenter,":[107],"multiregional,":[108],"multicohort,":[109],"phase":[110],"trial":[112],"cosibelimab.":[114],"METHODS:":[115],"In":[116],"this":[117],"trial,":[118],"participants":[119,168,219],"received":[123],"cosibelimab":[124],"800":[125],"mg":[126],"intravenously":[127],"every":[128],"2":[129],"weeks.":[130],"Primary":[131],"endpoint":[132],"was":[133,162,191,245],"objective":[134],"response":[135,155,161,200],"rate":[136],"(ORR)":[137],"independent":[139],"central":[140],"review":[141],"using":[142],"Response":[143],"Evaluation":[144],"Criteria":[145],"in":[146,164,202],"Solid":[147],"Tumors,":[148],"V.1.1.":[149],"Secondary":[150],"endpoints":[151],"included":[152],"duration":[153],"(DOR)":[156],"safety.":[158],"RESULTS:":[159],"Objective":[160],"observed":[163],"37":[165],"78":[167],"(47.4%":[169],"(95%":[170],"CI:":[171],"36.0%":[172],"59.1%)),":[174],"median":[176],"follow-up":[177],"15.4":[179],"months":[180],"(range:":[181,194],"0.4":[182],"40.5)":[184],"as":[185],"data":[187],"cut-off.":[188],"Median":[189],"DOR":[190,243],"not":[192],"reached":[193],"1.4+":[195],"34.1+":[197],"months),":[198],"ongoing":[201],"73.0%":[203],"participants.":[205],"Common":[206],"treatment-emergent":[207],"AEs":[208,223],"(\u226515%)":[209],"were":[210,234],"fatigue":[211],"(26.9%),":[212],"rash":[213],"(16.7%),":[214],"anemia":[216],"(15.4%).":[217],"Eighteen":[218],"(23.1%)":[220],"experienced":[221],"(grade":[224],"3:":[225],"n=2":[226],"(2.6%);":[227],"no":[228],"grade":[229],"4/5).":[230],"No":[231],"treatment-related":[232],"deaths":[233],"reported.":[235],"CONCLUSIONS:":[236],"demonstrated":[238],"clinically":[239],"meaningful":[240],"ORR":[241],"associated":[246],"manageable":[249],"safety":[250],"profile.":[251],"TRIAL":[252],"REGISTRATION":[253],"NUMBER:":[254],"NCT03212404.":[255]},"counts_by_year":[{"year":2026,"cited_by_count":26},{"year":2025,"cited_by_count":26},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2023-10-18T00:00:00"}